Showing results (1301-1310 of 1,406) with videos related to
Sort By:
Pageof 141
Advances in Therapy|September 3, 2015
Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis BJin-Lin Hou, Daozheng Xu, Guangfeng Shi, et al.Journal of Clinical Immunology|April 14, 2011
Lack of association between ORAI1/CRACM1 gene polymorphisms and Kawasaki disease in the Taiwanese childrenHo-Chang Kuo, Ying-Jui Lin, Suh-Hang Hank Juo, et al.Journal of Neurology|October 17, 2023
Mitochondrial myopathy without extraocular muscle involvement: a unique clinicopathologic profileYan Lin, Jiayin Wang, Hong Ren, et al.The Journal of Nutritional Biochemistry|November 11, 2019
Resveratrol treatment improves the altered metabolism and related dysbiosis of gut programed by prenatal high-fat diet and postnatal high-fat diet exposureYi-Chuan Huang, Li-Tung Huang, Jiunn-Ming Sheen, et al.Immunobiology|February 18, 2011
Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES)Wen-I Lee, Jing-Long Huang, Syh-Jae Lin, et al.Frontiers in Aging Neuroscience|March 25, 2024
Physical exercise frequency and cognition: a multicenter cross-sectional cohort studyChen Wen, Jing-Huan Gan, Guo-Wei Huang, et al.Kidney International|June 4, 2015
Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosisJingyuan Xie, Xu Hao, Evren U Azeloglu, et al.Journal of Cellular Physiology|May 14, 2011
Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cellsWen-Shih Huang, Chih-Chien Chin, Cheng-Nan Chen, et al.Journal of Biomedical Science|June 16, 2014
Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cellsYung-Yu Hsieh, Chien-Heng Shen, Wen-Shih Huang, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 4, 2022
Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian PopulationXueqing Yu, Nan Chen, Jun Xue, et al.Pageof 141